𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of anAndrographis paniculatacomposition for the relief of rheumatoid arthritis symptoms: a prospective randomized placebo-controlled trial

✍ Scribed by R. A. Burgos; J. L. Hancke; J. C. Bertoglio; V. Aguirre; S. Arriagada; M. Calvo; D. D. Cáceres

Publisher
Springer
Year
2009
Tongue
English
Weight
301 KB
Volume
28
Category
Article
ISSN
0770-3198

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of methotrexate treatment in pa
Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double-blind, randomized, placebo-controlled trial
✍ Henrike van Dongen; Jill van Aken; Leroy R. Lard; Karen Visser; H. Karel Ronday; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract ## Objective To determine whether patients with undifferentiated arthritis (UA; inflammatory, nontraumatic arthritis that cannot be diagnosed using current classification criteria) benefit from treatment with methotrexate (MTX). ## Methods The PRObable rheumatoid arthritis: Methotrex

A randomized, placebo-controlled trial o
A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis
✍ Nicolino Ruperto; Daniel J. Lovell; Ruben Cuttica; Nick Wilkinson; Patricia Woo; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

## Abstract ## Objective To evaluate the safety and efficacy of infliximab in the treatment of juvenile rheumatoid arthritis (JRA). ## Methods This was an international, multicenter, randomized, placebo‐controlled, double‐blind study. One hundred twenty‐two children with persistent polyarticular

Combination of infliximab and methotrexa
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial
✍ E. William St. Clair; Désirée M. F. M. van der Heijde; Josef S. Smolen; Ravinder 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 2 views

## Abstract ## Objective To compare the benefits of initiating treatment with methotrexate (MTX) and infliximab (anti–tumor necrosis factor α [anti‐TNFα] monoclonal antibody) with those of MTX treatment alone in patients with rheumatoid arthritis (RA) of ≤3 years' duration. ## Methods RA patient